📖 Approx. 3 min ／ Updated 2026.06.17
In this article, an M&A advisor specializing in the medical industry will explain from a practical perspective what points **business valuation** and **corporate demergers** entail in business succession and medical M&A. We will provide specific countermeasures based on DCF, net asset value, comparable company analysis, and the restrictions and utilization under the Medical Care Act.
1. Industry Background of Corporate Demergers and Business Valuation
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the business environment for medical institutions, including business valuation, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, rising personnel costs, and the burden of capital investment. Particularly from the perspective of DCF, net asset value, and comparable company analysis, interest in third-party succession M&A is growing.
At the same time, corporate demergers are an important point in medical M&A practice. By appropriately designing the restrictions and utilization under the Medical Care Act, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the business flow, patient base, and equipment status specific to business valuation, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical specialty. DCF, net asset value, and comparable company analysis are key to business valuation.
- Corporate Demerger Design: Select the optimal scheme based on the restrictions and utilization under the Medical Care Act. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees that match the medical specialty characteristics from a nationwide network. Carefully coordinate desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to business valuation.
- Final Agreement & Closing: Conclude the final agreement, including representations, warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations in Business Valuation
In medical institution M&A involving business valuation, **DCF, net asset value, and comparable company analysis** hold the key to successful succession. There are numerous individual points depending on the medical specialty, such as the continuity of the patient base, maintaining employment of staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics specific to business valuation, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is important. Leveraging our track record in supporting business valuation succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Corporate Demergers
Corporate demergers are an area requiring specialized consideration in medical M&A. Design based on the restrictions and utilization under the Medical Care Act is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing mutually agreeable terms for both the transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be helpful if you could prepare the financial statements for the last three fiscal years, patient trend data, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for business valuation transfers?
A. Business valuation is based on DCF, net asset value, and comparable company analysis. For clinics without beds, it’s typically 0.5 to 1.5 times annual revenue, and for hospitals with beds, EBITDA multiples of 3 to 7 times are a guideline. We will provide details in a free preliminary assessment.
Q. What are the precautions when proceeding with a corporate demerger?
A. Prior design based on the restrictions and utilization under the Medical Care Act is essential. Seamless execution of practical matters through expert collaboration is key to success.
Q. Will staff and patients be informed of the consultation?
A. Information will be disclosed on a limited basis after an NDA is signed, and no disclosure to stakeholders will occur before the final agreement. Strict confidentiality is maintained.
Related Columns
- Complete Guide to Business Succession for Hospitals and Medical Corporations | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Clinic Sales and Transfers | Price Trends, Procedures, and Considerations Explained by Medical M&A Experts
- How to Proceed with Medical M&A and Hospital Succession | 6 Steps from Consultation to Agreement Explained with Case Studies
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and Certified Public Accountants
For consultations on Corporate Demergers and Business Valuation, contact M&A Medical.
Strict Confidentiality – Free Initial Consultation – Success Fee Basis